youtube_live
Q3 2026 earnings • released • EPS miss -၁၈.၆၅%
See resultschevron_right
MLYS:NASDAQ
Mineralys Therapeutics Inc
၁၅.၂၄ US$
arrow_downward
-၁၀.၃၅%(-၁.၇၆) 1D
၁၅.၂၉ US$
arrow_upward
+၀.၃၃% (+၀.၀၅၀)bedtimeAfter hours
Closed: နို ၅, GMT-၅ ၁၆:၀၀:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MLYS...
Open
၁၇.၆၆ US$
High
၁၇.၆၆ US$
Low
၁၅.၁၅ US$
Mkt. cap
၁၃၄.၇၃ ဋေ
Avg. vol.
၁.၆၆ သန်း
Volume
၂.၅၅ သန်း
52-wk high
၄၇.၆၅ US$
52-wk low
၁၅.၁၅ US$
EPS
-၄.၂၄ US$
Beta
၀.၈၃
Shares outstanding
၈.၈၄ ကုဋေ
No. of employees
၇၆
Open
၁၇.၆၆ US$
High
၁၇.၆၆ US$
Low
၁၅.၁၅ US$
Mkt. cap
၁၃၄.၇၃ ဋေ
Avg. vol.
၁.၆၆ သန်း
Volume
၂.၅၅ သန်း
52-wk high
၄၇.၆၅ US$
52-wk low
၁၅.၁၅ US$
EPS
-၄.၂၄ US$
Beta
၀.၈၃
Shares outstanding
၈.၈၄ ကုဋေ
No. of employees
၇၆
News stories
From web sources and news partners
kalkine.ca
·
ပြီးခဲ့သည့် ၄ နာရီ
What Pushes Mineralys Therapeutics (NASDAQ:MLYS) G&A to USD 37.4 Million Before December 22?
GuruFocus
·
ပြီးခဲ့သည့် ၁၄ နာရီ
Mineralys Therapeutics Inc (MLYS) Q3 2026 Earnings Call Highligh
Yahoo Finance Singapore
·
ပြီးခဲ့သည့် ၁၆ နာရီ
Mineralys Therapeutics (MLYS) Publishes Lorundrostat CKD Data, Is The Stock Still A Bargain?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၈ နာရီ
What Mineralys Therapeutics (MLYS) Said on Its Q3 Earnings Call
About Mineralys Therapeutics Inc